Abstract:Comparative genomic in situ hybridization (CGH) provides a new possibility for searching genomes for imbalanced genetic material. Labeled genomic test DNA, prepared from clinical or tumor specimens, is mixed with differently labeled control DNA prepared from cells with normal chromosome complements. The mixed probe is used for chromosomal in situ suppression (CISS) hybridization to normal metaphase spreads (CGH-metaphase spreads). Hybridized test and control DNA sequences are detected via different fluorochromes, e.g., fluorescein isothiocyanate (FITC) and tetraethylrhodamine isothiocyanate (TRITC). The ratios of FITC/TRITC fluorescence intensities for each chromosome or chromosome segment should then reflect its relative copy number in the test genome compared with the control genome, e.g., 0.5 for monosomies, 1 for disomies, 1.5 for trisomies, etc. Initially, model experiments were designed to test the accuracy of fluorescence ratio measurements on single chromosomes. DNAs from up to five human chromosome-specific plasmid libraries were labeled with biotin and digoxigenin in different hapten proportions. Probe mixtures were used for CISS hybridization to normal human metaphase spreads and detected with FITC and TRITC. An epifluorescence microscope equipped with a cooled charge coupled device (CCD) camera was used for image acquisition. Procedures for fluorescence ratio measurements were developed on the basis of commercial image analysis software. For hapten ratios 4/1, 1/1 and 1/4, fluorescence ratio values measured for individual chromosomes could be used as a single reliable parameter for chromosome identification. Our findings indicate (1) a tight correlation of fluorescence ratio values with hapten ratios, and (2) the potential of fluorescence ratio measurements for multiple color chromosome painting. Subsequently, genomic test DNAs, prepared from a patient with Down syndrome, from blood of a patient with T-cell prolymphocytic leukemia, and from cultured cells of a renal papillary carcinoma cell line, were applied in CGH experiments. As expected, significant differences in the fluorescence ratios could be measured for chromosome types present in different copy numbers in these test genomes, including a trisomy of chromosome 21, the smallest autosome of the human complement. In addition, chromosome material involved in partial gains and losses of the different tumors could be mapped to their normal chromosome counterparts in CGH-metaphase spreads. An alternative and simpler evaluation procedure based on visual inspection of CCD images of CGH-metaphase spreads also yielded consistent results from several independent observers. Pitfalls, methodological improvements, and potential applications of CGH analyses are discussed.

Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization

[The Application of Dual-Color Fluorescence in Situ Hybridization to the Diagnosis of Klinefelter Syndrome].

Using SNP array to identify aneuploidy and segmental imbalance in translocation carriers.

Detection of Cryptic Balanced Chromosomal Rearrangements Using High-Resolution Optical Genome Mapping

External Quality Assessment of Prenatal Diagnosis of a Rare and Subtle Chromosomal Structural Abnormality.

Development Of A Focused Oligonucleotide-Array Comparative Genomic Hybridization Chip For Clinical Diagnosis Of Genomic Imbalance

Analytical and clinical validity of whole-genome oligonucleotide array comparative genomic hybridization for pediatric patients with mental retardation and developmental delay.

Detection of Aneuploidy from Single Cells by Array-Comparative Genetic Hybridization

Karyotyping of Comparative Genomic Hybridization Human Metaphases by Using Support Vector Machines

Chromosomes 5, 7 and 8 abnormalities in myelodysplastic syndromes by using interphase fluorescence in situ hybridization

Microarray comparative genomic hybridization detection of chromosomal imbalances in uterine cervix carcinoma

Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.

Advancement in Study on Comparative Genomic Hybridization

Clinical implementation of whole-genome array CGH as a first-tier test in 5080 pre and postnatal cases

Genome-wide analysis of DNA copy-number changes using cDNA microarrays

[Detection of Chromosomal Aberration in Sporadic Colorectal Cancer with Comparative Genomic Hybridization].

Long range haplotyping of paired-homologous chromosomes by single-chromosome sequencing of a single cell

Karyotyping of Comparative Genomic Hybridization Human Metaphases Using Kernel Nearest-Neighbor Algorithm

Optical Genome Mapping as a Potential Routine Clinical Diagnostic Method

Cancer Sample Analysis Utilizing Single-Nucleotide Polymorphism Array and Array Comparative Genomic Hybridization

The Application of Universal Linkage System in Comparative Genomic Hybridization of Formalin-fixed, Paraffin-embedded Bladder Cancer Tissues